Type 1 diabetes: treatment [sounds like]
361 results
101 - 200
Short‐acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus
Eye symptoms and signs of systemic diseases - Insulin therapy in type 2 diabetes
- Exercise and diet for preventing type 2 diabetes mellitus
- Hypoglycaemia in a patient with diabetes
- Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus
- Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2
Home glucose monitoring offers no benefit to patients not using insulin- GLP-1 analogues for weight loss among patients with type 2 diabetes
- Guidelines for when to consider mortality-reducing treatments for patients with type 2 diabetes
- Enhanced glucose control for preventing and treating diabetic neuropathy in type 1 diabetes
- Glucagon-like peptide analogues (GLP-1 analogues) for type 2 diabetes
- Incidental glucosuria in children
- Comprehensive treatment and follow-up of type 2 diabetes
- Sodium‐glucose co‐transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes
- Follow-up of type 1 diabetes
- J-shaped survival curve for glycemic control in patients with type 2 DM
- Interventions for people with type 2 diabetes mellitus fasting during Ramadan
- AHA/ACC guideline for the primary prevention of stroke
- Fenofibrate for diabetic retinopathy
- Treatment of periodontitis for glycaemic control in people with diabetes mellitus
- Glucagon-like peptide analogues for type 2 diabetes mellitus: Cochrane systematic review
- Intensive control of blood sugar (HbA1c < 7.0%) in DM2 may be harmful (ACCORD)
- Glucose targets for preventing diabetic kidney disease and its progression
- Metabolic syndrome
- Metformin and second‐ or third‐generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus
- Diet and exercise counseling does not reduce cardiovascular or all-cause mortality associated with prediabetes and type 2 diabetes
- Acetyl‐L‐carnitine for the treatment of diabetic peripheral neuropathy
- Severe hypoglycemic episodes raise risk of dementia in adults with T2DM
- Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus
- Dietary advice and exercise for type 2 diabetes mellitus
- Reducing cardiovascular events by multifactorial intervention in patients with type 2 diabetes
- SGLT-2 inhibitors in type 2 diabetes
- Insulin added on metformin in type 2 diabetes
- Blood pressure control for diabetic retinopathy
- Altered dietary salt intake for preventing diabetic kidney disease and its progression
- Hormonal versus non‐hormonal contraceptives in women with diabetes mellitus type 1 and 2
- USPSTF 2017 does not recommend for or against screening for celiac disease in asymptomatic patients (I statement)
- Gestational diabetes mellitus (GDM)
- Self-monitoring ineffective in patients with diabetes (ESMON)
- Peroxisome proliferator‐activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack
- Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis
- SGLT-2 inhibitors or GLP-1 receptor agonists reduce cardiovascular outcomes in patients with type 2 diabetes
- Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy
- Proteinuria
- Risk of severe hypoglycemia similar between different insulin formulations
- NICE guidelines for diabetes mellitus, type 2
- Chinese herbal medicines for people with impaired glucose tolerance or impaired fasting blood glucose
- Diabetic kidney disease (diabetic nephropathy)
- ADA/EASD updated guidelines: glycemic control is only part of the management of type 2 diabetes
- Group based training for self-management strategies in people with type 2 diabetes mellitus
- Effect of the treatment of type 2 diabetes mellitus on the development of cognitive impairment and dementia
- Sulphonylurea for type 2 diabetes
- Alpha‐lipoic acid for diabetic peripheral neuropathy
- Fenofibrate decreases amputation in patients with type 2 DM (FIELD)
- Air travel and illness
- (Ultra‐)long‐acting insulin analogues for people with type 1 diabetes mellitus
- Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients
- Metformin should be initial therapy for adults with type 2 DM
- Association of glycaemic control and complications of type 2 diabetes
- Glycaemic control for slowing the progression of microvascular complications in diabetes mellitus
- Prevention of type 2 diabetes in persons at increased risk for the development of T2D
- Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control
- Hypothyroidism in children
- Lifestyle interventions for the treatment of women with gestational diabetes
- GLP-1 agonists associated with lower stroke risk in patients with type 2 diabetes at high risk for cardiovascular disease
- Ayurvedic treatments for diabetes mellitus: Cochrane systematic review
- Intensive versus conventional glycaemic control for treating diabetic foot ulcers
- Prevention of type 2 diabetes by life-style changes
- Gestational diabetes mellitus and future risk of diabetes
- Dipeptidyl‐peptidase (DPP)‐4 inhibitors and glucagon‐like peptide (GLP)‐1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus
- Unintentional weight loss in adults
- Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes
- Oral antidiabetic drugs and GLP-1 analogues
- Continuous glucose monitoring systems for type 1 diabetes mellitus
- Scoliosis and kyphosis
- Intensive glucose control ineffective in ICU patients
- Relaxed hemoglobin A1c goals for T2DM from the American College of Physicians
- Diabetic ketoacidosis
- Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings
- High-dose B-vitamins harmful to patients with diabetic nephropathy
- Newer hypoglycemics don't increase or decrease mortality
- Oral anti‐diabetic pharmacological therapies for the treatment of women with gestational diabetes
- SGLT-2 inhibitors and GLP-1 agonists for diabetes and chronic kidney disease
- Diagnosis and treatment of childhood hypercholesterolaemia
- Gout and pseudogout
- Conservative (non-surgical) treatment of obesity